The findings raise the hope that, by targeting these immune cells, it may be possible to treat the most common type of dementia.
A new treatment for Alzheimer’s disease approved by the Food and Drug Administration this month is just the start, says UW Medicine behavioral neurologist Dr. Michael Rosenbloom.
New opportunity to connect with others and enjoy the outdoors launched this month for people diagnosed before age 65.
Neighboring organizations will come together in honor of Alzheimer’s and Brain Health Awareness Month.
RNA contact with tau protein spurs neurofibrillary tangles in the brain — a defining hallmark of Alzheimer’s and other diseases.
A variety of resources and enjoyable activities are offered for people with memory loss, their caregivers and families.
Most Alzheimer’s drugs in development target beta-amyloid, but targeting another protein, called tau, may be needed.
Patients in need of cataract surgery also see their risk for developing dementia drop by 30% after undergoing the operation, according to new research published today in JAMA Internal Medicine.
Results reported in JAMA Internal Medicine associate cataract surgery with 30% lower risk of dementia in aging population.
Researchers examine links to cognitive decline of hearing loss, military service, and timeliness of diagnosis.